Effects of berbamine against myocardial ischemia/reperfusion injury: Activation of the 5' adenosine monophosphate‐activated protein kinase/nuclear factor erythroid 2‐related factor pathway and changes in the mitochondrial state. (7th February 2022)
- Record Type:
- Journal Article
- Title:
- Effects of berbamine against myocardial ischemia/reperfusion injury: Activation of the 5' adenosine monophosphate‐activated protein kinase/nuclear factor erythroid 2‐related factor pathway and changes in the mitochondrial state. (7th February 2022)
- Main Title:
- Effects of berbamine against myocardial ischemia/reperfusion injury: Activation of the 5' adenosine monophosphate‐activated protein kinase/nuclear factor erythroid 2‐related factor pathway and changes in the mitochondrial state
- Authors:
- Xu, Chennian
Liu, Yang
Yang, Jian
Zhai, Mengen
Fan, Zhenge
Qiao, Rui
Jin, Ping
Yang, Lifang - Abstract:
- Abstract: This study was designed to investigate whether berbamine (BA)‐induced cardioprotective effects were related to 5′ adenosine monophosphate‐activated protein kinase (AMPK)/nuclear factor erythroid 2‐related factor (Nrf2) signaling and changes in the mitochondria in myocardial ischemia/reperfusion (I/R) injury. C57/BL6 mice were exposed to BA (10 mg/kg/d), with or without administration of the AMPK specific inhibitor compound C (5 mg/kg/d) or the Nrf2 specific inhibitor ML‐385 (30 mg/kg/d), and then subjected to a myocardial I/R operation. As expected, BA significantly improved post‐ischemic cardiac function, reduced infarct size and apoptotic cell death, decreased oxidative stress, and improved the mitochondrial state. Furthermore, BA markedly increased AMPK activation, Nrf2 nuclear translocation, and the levels of NAD(P)H quinone dehydrogenase and heme oxygenase‐1. Nevertheless, these BA‐induced changes were abrogated by compound C. In addition, ML‐385 also canceled the cardioprotective effects of BA but had little effect on AMPK activation. Our results demonstrate that BA alleviates myocardial I/R injury and the mitochondrial state by inhibiting apoptosis and oxidative stress via the AMPK/Nrf2 signaling pathway.
- Is Part Of:
- BioFactors. Volume 48:Number 3(2022)
- Journal:
- BioFactors
- Issue:
- Volume 48:Number 3(2022)
- Issue Display:
- Volume 48, Issue 3 (2022)
- Year:
- 2022
- Volume:
- 48
- Issue:
- 3
- Issue Sort Value:
- 2022-0048-0003-0000
- Page Start:
- 651
- Page End:
- 664
- Publication Date:
- 2022-02-07
- Subjects:
- AMPK/Nrf2 -- berbamine -- heart -- ischemia/reperfusion injury -- mitochondrion -- oxidative stress
Vitamins -- Physiological effect -- Periodicals
Trace elements -- Physiological effect -- Periodicals
Growth factors -- Physiological effect -- Periodicals
Plant growth promoting substances -- Physiological effect -- Periodicals
Biochemistry -- Periodicals
Nutritional Physiological Phenomena -- Periodicals
Trace Elements -- metabolism -- Periodicals
Vitamins -- metabolism -- Periodicals
Molecular Biology -- Periodicals
612.399 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1872-8081 ↗
http://search.epnet.com/direct.asp?jid=BFT&db=afh ↗
http://www.ebscohost.com ↗
http://www3.interscience.wiley.com/journal/121452383/ ↗
http://onlinelibrary.wiley.com/ ↗
http://firstsearch.oclc.org ↗
http://firstsearch.oclc.org/journal=0951-6433;screen=info;ECOIP ↗ - DOI:
- 10.1002/biof.1820 ↗
- Languages:
- English
- ISSNs:
- 0951-6433
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 2072.123000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21828.xml